glp-1 receptor agonist long term side effects medication for diabetes and weight loss A clinician's perspective π GLP-1
Description
Thyroid Function The FDA label for semaglutide includes a black box warning about thyroid C-cell tumors, based on animal studies
Accessed 24 Dec 2021
The industry is developing new treatments to counteract this
We found no significant association between T2D and mood disorders (Supplementary Table S6)
Endocrinology (1998) 139:6
Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy
